After graduating in Australia I completed my medical oncology training in 2012. After this I moved to the UK to undertake a fellowship in Oxford in the early phase clinical trial unit. After this, I completed a PhD at Oxford, specifically looking at associations between the BRAF mutation and angiogenesis in Melanoma. I obtained a consultant post in Oxford in 2019 and currently specialise in lung cancer, melanoma and neuroendocrine tumours. I have almost 10 years of experience with immunotherapy and have seen it evolve throughout the years into a mainstream therapeutic for the treatment of cancer.